Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation
Condition(s):Hepatitis B, ChronicLast Updated:January 18, 2016Withdrawn
Hide Studies Not Open or Pending
Condition(s):Hepatitis B, ChronicLast Updated:January 18, 2016Withdrawn
Condition(s):Chronic Hepatitis BLast Updated:October 10, 2023Recruiting
Condition(s):Hepatitis B; Liver TransplantationLast Updated:November 1, 2013Completed
Condition(s):Hepatitis BLast Updated:September 28, 2015Completed
Condition(s):Hepatitis B Virus Associated Liver DiseaseLast Updated:January 22, 2019Completed
Condition(s):Hepatitis B, ChronicLast Updated:February 6, 2009Completed
Condition(s):Hepatocellular Carcinoma; HBVLast Updated:January 18, 2024Not yet recruiting
Condition(s):Chronic Hepatitis BLast Updated:March 14, 2014Completed
Condition(s):Chronic Hepatitis BLast Updated:April 6, 2022Withdrawn
Condition(s):Hepatitis B; Liver TransplantationLast Updated:February 25, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.